Streetbeat News

Regulatory

HIMS

LLY

NVO

Novo Nordisk has requested the FDA to halt the production of compounded versions of its drugs Wegovy and Ozempic due to safety concerns. The demand for these cheaper alternatives has increased due to shortages and high costs of the branded drugs. Novo Nordisk is also involved in legal actions against compounding pharmacies.

Portfolio Pulse from Shivdeep Dhaliwal

October 24, 2024 | 12:23 am

CTNT

Trading for an unspecified asset was halted at 7:50:00 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 11:50 pm

AMGN

AZN

CTLT

GPCR

NVO

PFE

RHHBY

VKTX

Roche's Q3 sales rose 9% to $17.5 billion, driven by Ocrevus and Vabysmo. Roche urges regulators to block Novo Holdings' $16.5B acquisition of Catalent, citing potential negative industry impacts. The acquisition could affect competition in the GLP-1 market, where several companies, including Roche, have therapies in development.

Portfolio Pulse from Vandana Singh

October 23, 2024 | 11:05 pm

GRAL

GRAIL presented early results from the REFLECTION Real-World Evidence Study, showing that a veteran cohort had a cancer signal detection rate consistent with other populations using the MCED test. The findings were shared at the 2024 Early Detection of Cancer Conference.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 10:06 pm

MCD

The USDA is investigating the safety of McDonald's ground beef patties following an E.Coli outbreak, although slivered onions are suspected as the source. A state partner has collected samples for testing.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 9:25 pm

SANW

S&W Seed Company (NASDAQ:SANW) received a non-compliance notice from Nasdaq for failing to file its Annual Report on time. The company has 60 days to submit a compliance plan to avoid potential delisting.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 9:08 pm

PXDT

Pixie Dust Technologies announced plans to delist its ADRs from NASDAQ and deregister with the SEC. The company initially listed in August 2023 to access U.S. capital markets but has now decided to withdraw.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 9:01 pm

EA

MSFT

TTWO

WBD

SAG-AFTRA has secured over 120 AI agreements with 49 gaming companies, focusing on actor protections in AI usage. Upcoming negotiations with major developers like Activision, EA, WB, and Take-Two aim to extend these protections.

Portfolio Pulse from Franca Quarneti

October 23, 2024 | 8:53 pm

KRT

Karat Packaging has reported unauthorized access to its information systems. The company has activated its cybersecurity response plan and notified federal law enforcement. The investigation is ongoing, but no business disruption has been detected, and the incident is considered non-material.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 8:47 pm

PFE

Pfizer announced that the CDC's Advisory Committee on Immunization Practice has voted to expand the recommendation for the use of certain pneumococcal vaccines, including PREVNAR 20, for all adults aged 50 and older.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 8:47 pm